Jiangbo Pharmaceuticals Inc's ticker is JGBO and the CUSIP is 47737R101. A total of 1 filers reported holding Jiangbo Pharmaceuticals Inc in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 744,696 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 744,696 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $19,000 | – | 744,696 | 0.0% | 0.01% | – |
| Q2 2015 | $0 | -100.0% | 744,696 | -50.0% | 0.00% | -100.0% |
| Q1 2015 | $38,000 | +100.0% | 1,489,392 | +100.0% | 0.02% | +6.7% |
| Q4 2014 | $19,000 | 0.0% | 744,696 | 0.0% | 0.02% | +36.4% |
| Q3 2014 | $19,000 | 0.0% | 744,696 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $19,000 | 0.0% | 744,696 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $19,000 | +5.6% | 744,696 | 0.0% | 0.01% | -56.0% |
| Q4 2013 | $18,000 | -5.3% | 744,696 | 0.0% | 0.02% | -7.4% |
| Q3 2013 | $19,000 | -63.5% | 744,696 | 0.0% | 0.03% | -68.6% |
| Q2 2013 | $52,000 | – | 744,696 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 744,696 | $0 | 0.00% |